News

Kemwell BioPharma drives quality excellence with Veeva Vault QMS

Kemwell will be able to transform its operations with speed and precision, raising quality excellence across the company’s research and manufacturing facilities

Veeva Systemsannounced that Kemwell BioPharma, India’s largest biologics contract development and manufacturing organization (CDMO), has implemented the Veeva Vault Quality Management System (QMS) across its development and manufacturing operations. With Vault QMS, Kemwell will be able to transform its operations with speed and precision, raising quality excellence across the company’s research and manufacturing facilities.

“Veeva is a trusted partner for quality management, and adopting its industry-leading solutions will provide the foundation to execute toward our vision of rapid expansion across 40 countries worldwide,” said Deepak Gupta, Vice President of Quality, Kemwell. “Veeva Vault QMS will play a pivotal role in helping us achieve regulatory compliance while aligning with the best practices of our clients.”

Vault QMS features pre-configured QMS processes based on industry best practices, enabling Kemwell to drive efficiency and quality. Using a quality system on a cloud-based platform, Kemwell will be able to foster seamless collaboration with stakeholders while ensuring greater transparency across customers, auditors, and regulatory agencies. This transition to a modern QMS will enhance the company’s quality processes and further its leadership in biologics contract development and manufacturing.

“We are proud to partner with Kemwell to support their digital quality transformation,” said Varadarajan Srinivasan, general manager, 

Veeva Vault Quality India. “Veeva Vault QMS will deliver a strong quality foundation to streamline processes and accelerate time-to-market for our clients on potentially life-changing medicines.”

Veeva Vault QMS is part of Veeva Quality Suite, bringing together quality, content, lab, and training management applications on a single cloud platform.

 

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Back to top button
Close
Close